Presentation Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R) February 09, 2017 REGISTER for free or LOG IN to view this content Clinical Cardiology Structural Heart Aortic Valve Factoid Up Next Presentation 10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents February 13, 2017 More slides + Presentation Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents February 13, 2017 Presentation Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD Presenter: Jens Wiebe February 16, 0017 We Recommend
Presentation 10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents February 13, 2017
Presentation Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents February 13, 2017
Presentation Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD Presenter: Jens Wiebe February 16, 0017